CXCL1 inhibits airway smooth muscle cell migration through the decoy receptor duffy antigen receptor for chemokines

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1416-1426

  Al Alwan, Laila A ^a   Chang, Ying ^a   Rousseau, Simon ^a   Martin, James G ^a   Eidelman, David H ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE DUFFY ANTIGEN RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AIRWAY; AIRWAY SMOOTH MUSCLE CELL; ALPHA CHAIN; APOPTOSIS ASSAY; ARTICLE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

AIRWAY REMODELING; BIOLOGICAL MARKERS; CELL MIGRATION INHIBITION; CHEMOKINE CXCL1; CHEMOKINE CXCL2; DUFFY BLOOD-GROUP SYSTEM; HUMANS; MAP KINASE SIGNALING SYSTEM; PRIMARY CELL CULTURE; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-8B;

EID: 84906084958     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302860     Document Type: Article

References (69)

1. Majesky, M. W., and S. M. Schwartz. 1990. Smooth muscle diversity in arterial wound repair. Toxicol. Pathol. 18: 554-559.
2. Hatten, M. E. 1993. The role of migration in central nervous system neuronal development. Curr. Opin. Neurobiol. 3: 38-44.
3. Ikawa, M., N. Inoue, A. M. Benham, and M. Okabe. 2010. Fertilization: a sperm's journey to and interaction with the oocyte. J. Clin. Invest. 120: 984-994.
4. Fan, D., A. Takawale, J. Lee, and Z. Kassiri. 2012. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 5: 15.
5. Pickens, S. R., N. D. Chamberlain, M. V. Volin, R. M. Pope, N. E. Talarico, A. M. Mandelin, II, and S. Shahrara. 2012. Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis. Arthritis Rheum. 64: 2471-2481.
6. Zhang, Y., S. Takahashi, A. Tasaka, T. Yoshima, H. Ochi, and K. Chayama. 2013. Involvement of microRNA-224 in cell proliferation, migration, invasion and anti-apoptosis in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 28: 565-575.
7. Johnson, P. R., and J. K. Burgess. 2004. Airway smooth muscle and fibroblasts in the pathogenesis of asthma. Curr. Allergy Asthma Rep. 4: 102-108.
8. Schmidt, M., G. Sun, M. A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171: 380-389.
9. Yasukawa, A., K. Hosoki, M. Toda, Y. Miyake, Y. Matsushima, T. Matsumoto, D. Boveda-Ruiz, P. Gil-Bernabe, M. Nagao, M. Sugimoto, et al. 2013. Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells. PLoS ONE 8: e64281.
10. Saunders, R., S. Siddiqui, D. Kaur, C. Doe, A. Sutcliffe, F. Hollins, P. Bradding, A. Wardlaw, and C. E. Brightling. 2009. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J. Allergy Clin. Immunol. 123: 376-384.
11. Wang, C. H., C. D. Huang, H. C. Lin, K. Y. Lee, S. M. Lin, C. Y. Liu, K. H. Huang, Y. S. Ko, K. F. Chung, and H. P. Kuo. 2008. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 178: 583-591.
12. Walker, N., L. Badri, S. Wettlaufer, A. Flint, U. Sajjan, P. H. Krebsbach, V. G. Keshamouni, M. Peters-Golden, and V. N. Lama. 2011. Resident tissuespecific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am. J. Pathol. 178: 2461-2469.
13. Berair, R., R. Saunders, and C. E. Brightling. 2013. Origins of increased airway smooth muscle mass in asthma. BMC Med. 11: 145.
14. Nihlberg, K., K. Larsen, A. Hultgardh-Nilsson, A. Malmström, L. Bjermer, and G. Westergren-Thorsson. 2006. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir. Res. 7: 50.
15. Al-Alwan, L. A., Y. Chang, C. J. Baglole, P. A. Risse, A. J. Halayko, J. G. Martin, D. H. Eidelman, and Q. Hamid. 2012. Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17-induced growth-related oncogenes. J. Allergy Clin. Immunol. 130: 977-985.e6
16. De Filippo, K., A. Dudeck, M. Hasenberg, E. Nye, N. van Rooijen, K. Hartmann, M. Gunzer, A. Roers, and N. Hogg. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930-4937.
17. Kuo, P. L., K. H. Shen, S. H. Hung, and Y. L. Hsu. 2012. CXCL1/GROa increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kB/HDAC1 epigenetic regulation. Carcinogenesis 33: 2477-2487.
18. Jones, C. P., S. C. Pitchford, C. M. Lloyd, and S. M. Rankin. 2009. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells 27: 3074-3081.
19. Kroeze, K. L., M. A. Boink, S. C. Sampat-Sardjoepersad, T. Waaijman, R. J. Scheper, and S. Gibbs. 2012. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J. Invest. Dermatol. 132: 216-225.
20. Ahuja, S. K., and P. M. Murphy. 1996. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271: 20545-20550.
21. Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity 36: 705-716.
22. Luttrell, L. M. 2008. Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol. Biotechnol. 39: 239-264.
23. Graham, G. J., M. Locati, A. Mantovani, A. Rot, and M. Thelen. 2012. The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145: 30-38.
24. Cutbush, M., and P. L. Mollison. 1950. The Duffy blood group system. Heredity (Edinb) 4: 383-389.
25. Miller, L. H., S. J. Mason, J. A. Dvorak, M. H. McGinniss, and I. K. Rothman. 1975. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189: 561-563.
26. Horuk, R., C. E. Chitnis, W. C. Darbonne, T. J. Colby, A. Rybicki, T. J. Hadley, and L. H. Miller. 1993. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182-1184.
27. Chaudhuri, A., V. Zbrzezna, J. Polyakova, A. O. Pogo, J. Hesselgesser, and R. Horuk. 1994. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J. Biol. Chem. 269: 7835-7838.
28. Luan, J., Y. Furuta, J. Du, and A. Richmond. 2001. Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Cytokine 14: 253-263.
29. Fukuma, N., N. Akimitsu, H. Hamamoto, H. Kusuhara, Y. Sugiyama, and K. Sekimizu. 2003. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem. Biophys. Res. Commun. 303: 137-139.
30. Lee, J. S., C. W. Frevert, M. M. Wurfel, S. C. Peiper, V. A.Wong, K. K. Ballman, J. T. Ruzinski, J. S. Rhim, T. R. Martin, and R. B. Goodman. 2003. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J. Immunol. 170: 5244-5251.
31. Pruenster, M., L. Mudde, P. Bombosi, S. Dimitrova, M. Zsak, J. Middleton, A. Richmond, G. J. Graham, S. Segerer, R. J. Nibbs, and A. Rot. 2009. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10: 101-108.
32. Govindaraju, V., M. C. Michoud, M. Al-Chalabi, P. Ferraro, W. S. Powell, and J. G. Martin. 2006. Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am. J. Physiol. Cell Physiol. 291: C957-C965.
33. Goncharova, E. A., D. A. Goncharov, and V. P. Krymskaya. 2006. Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration. Nat. Protoc. 1: 2933-2939.
34. Sebolt-Leopold, J. S., D. T. Dudley, R. Herrera, K. Van Becelaere, A. Wiland, R. C. Gowan, H. Tecle, S. D. Barrett, A. Bridges, S. Przybranowski, et al. 1999. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5: 810-816.
35. Giubellino, A., C. Sourbier, M. J. Lee, B. Scroggins, P. Bullova, M. Landau, W. Ying, L. Neckers, J. B. Trepel, and K. Pacak. 2013. Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. PLoS ONE 8: e56083.
36. Schneider, C. A., W. S. Rasband, and K. W. Eliceiri. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9: 671-675.
37. Al-Alwan, L. A., Y. Chang, A. Mogas, A. J. Halayko, C. J. Baglole, J. G. Martin, S. Rousseau, D. H. Eidelman, and Q. Hamid. 2013. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration. J. Immunol. 191: 2731-2741.
38. Suganuma, N., S. Ito, H. Aso, M. Kondo, M. Sato, M. Sokabe, and Y. Hasegawa. 2012. STIM1 regulates platelet-derived growth factor-induced migration and Ca2+ influx in human airway smooth muscle cells. PLoS ONE 7: e45056.
39. Damaj, B. B., S. R. McColl, K. Neote, C. A. Hébert, and P. H. Naccache. 1996. Diverging signal transduction pathways activated by interleukin 8 (IL-8) and related chemokines in human neutrophils. IL-8 and Gro-alpha differentially stimulate calcium influx through IL-8 receptors A and B. J. Biol. Chem. 271: 20540-20544.
40. Milligan, G., and E. Kostenis. 2006. Heterotrimeric G-proteins: a short history. Br. J. Pharmacol. 147(Suppl. 1): S46-S55.
41. Horuk, R., A. Martin, J. Hesselgesser, T. Hadley, Z. H. Lu, Z. X. Wang, and S. C. Peiper. 1996. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. J. Leukoc. Biol. 59: 29-38.
42. Liu, X. H., T. J. Hadley, L. Xu, S. C. Peiper, and P. E. Ray. 1999. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int. 55: 1491-1500.
43. Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177.
44. Hedges, J. C., M. A. Dechert, I. A. Yamboliev, J. L. Martin, E. Hickey, L. A.Weber, andW. T. Gerthoffer. 1999. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 274: 24211-24219.
45. He, F., A. Kumar, and Z. H. Song. 2012. Heat shock protein 90 is an essential molecular chaperone for CB2 cannabinoid receptor-mediated signaling in trabecular meshwork cells. Mol. Vis. 18: 2839-2846.
46. Liu, D. H., H. Y. Yuan, C. Y. Cao, Z. P. Gao, B. Y. Zhu, H. L. Huang, and D. F. Liao. 2007. Heat shock protein 90 acts as a molecular chaperone in latephase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells. Acta Pharmacol. Sin. 28: 1907-1913.
47. Kobayakawa, T., S. Yamada, A. Mizuno, and T. K. Nemoto. 2008. Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. Cell Stress Chaperones 13: 97-104.
48. Gao, Y., S. Yechikov, A. E. Vazquez, D. Chen, and L. Nie. 2013. Distinct roles of molecular chaperones HSP90a and HSP90b in the biogenesis of KCNQ4 channels. PLoS ONE 8: e57282.
49. Cortes-Gonzalez, C., J. Barrera-Chimal, M. Ibarra-Sanchez, M. Gilbert, G. Gamba, A. Zentella, M. E. Flores, and N. A. Bobadilla. 2010. Opposite effect of Hsp90alpha and Hsp90beta on eNOS ability to produce nitric oxide or superoxide anion in human embryonic kidney cells. Cell. Physiol. Biochem. 26: 657-668.
50. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709.
51. Wehrle-Haller, B. 2012. Structure and function of focal adhesions. Curr. Opin. Cell Biol. 24: 116-124.
52. Aso, H., S. Ito, A. Mori, N. Suganuma, M. Morioka, N. Takahara, M. Kondo, and Y. Hasegawa. 2013. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Am. J. Respir. Cell Mol. Biol. 48: 322-329.
53. Ning, Y., Q. Sun, Y. Dong, W. Xu, W. Zhang, H. Huang, and Q. Li. 2011. Slit2-N inhibits PDGF-induced migration in rat airway smooth muscle cells: WASP and Arp2/3 involved. Toxicology 283: 32-40.
54. Luan, J., R. Shattuck-Brandt, H. Haghnegahdar, J. D. Owen, R. Strieter, M. Burdick, C. Nirodi, D. Beauchamp, K. N. Johnson, and A. Richmond. 1997. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62: 588-597.
55. Antoniou, K. M., A. Tzouvelekis, M. G. Alexandrakis, K. Sfiridaki, I. Tsiligianni, G. Rachiotis, N. Tzanakis, D. Bouros, J. Milic-Emili, and N. M. Siafakas. 2006. Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 130: 982-988.
56. Benelli, R., S. Stigliani, S. Minghelli, S. Carlone, and N. Ferrari. 2013. Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. Prostate 73: 941-951.
57. Alkhouri, H., L. M. Moir, C. L. Armour, and J. M. Hughes. 2014. CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro. Clin. Exp. Allergy 44: 381-392.
58. Vora, P., P. Pillai, J. Mustapha, C. Kowal, S. Shaffer, R. Bose, M. Namaka, and E. E. Frost. 2012. CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signaling. Exp. Neurol. 236: 259-267.
59. Vergara, C., Y. J. Tsai, A. V. Grant, N. Rafaels, L. Gao, T. Hand, M. Stockton, M. Campbell, D. Mercado, M. Faruque, et al. 2008. Gene encoding Duffy antigen/receptor for chemokines is associated with asthma and IgE in three populations. Am. J. Respir. Crit. Care Med. 178: 1017-1022.
60. Sun, G., Y. Wang, Y. Zhu, C. Huang, and Q. Ji. 2011. Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Otolaryngol. 131: 197-203.
61. Latini, F. R., A. U. Bastos, C. P. Arnoni, J. G. Muniz, R. M. Person, W. Baleotti, Jr., J. A. Barreto, L. Castilho, and J. M. Cerutti. 2013. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol. Dis. 50: 161-165.
62. Hesselgesser, J., C. E. Chitnis, L. H. Miller, D. G. Yansura, L. C. Simmons, W. J. Fairbrother, C. Kotts, C. Wirth, B. L. Gillece-Castro, and R. Horuk. 1995. A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J. Biol. Chem. 270: 11472-11476.
63. Vinet, J., M. van Zwam, I. M. Dijkstra, N. Brouwer, H. R. van Weering, A. Watts, M. Meijer, M. R. Fokkens, V. Kannan, D. Verzijl, et al. 2013. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR. Br. J. Pharmacol. 168: 1375-1387.
64. Goupil, E., S. A. Laporte, and T. E. Hébert. 2012. Functional selectivity in GPCR signaling: understanding the full spectrum of receptor conformations. Mini Rev. Med. Chem. 12: 817-830.
65. Maudsley, S., S. A. Patel, S. S. Park, L. M. Luttrell, and B. Martin. 2012. Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics. Mini Rev. Med. Chem. 12: 831-840.
66. Luttrell, L. M., F. L. Roudabush, E. W. Choy, W. E. Miller, M. E. Field, K. L. Pierce, and R. J. Lefkowitz. 2001. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98: 2449-2454.
67. Eishingdrelo, H., and S. Kongsamut. 2013. Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery. Curr. Chem. Genomics Transl. Med. 7: 9-15.
68. Wang, Y., Y. Zhan, R. Xu, R. Shao, J. Jiang, and Z. Wang. 2014. Src mediates extracellular signal-regulated kinase 1/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines. Mol. Carcinog. DOI: 10.1002/mc.22147.
69. Martel, G., J. Bérubé, and S. Rousseau. 2013. The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs). PLoS ONE 8: e59116.